CONMED Corporation (CNMD) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.

Total Revenue Chart for CONMED Corporation

CONMED Corporation (CNMD) revenue for FY2025 was USD 1.4B, a 5.2% change from FY2024. CONMED Corporation's revenue grew from USD 10.5M in 1986 to USD 1.4B in 2025 (12990.4% over 39 years). Earnings per share grew from USD 0.83 in 2000 to USD -2.68 in 2022 (-423.2%). Revenue compound annual growth rate: 5-year CAGR of 9.8%, 10-year CAGR of 6.7%, 20-year CAGR of 4.1%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$1.40B
Implied Share Price
$46.72
Enterprise Value
$2.17B
Revenue (TTM)
$1.37B
EBITDA
$227.46M
Profit Margin
4.12%
Trailing P/E
25.25
Forward P/E
27.17
Price/Book (MRQ)
1.33
Price/Sales (TTM)
1.02
EV/EBITDA
11.56
EV/Revenue
1.59
Dividend Yield
—
Book Value
$34.73
Free Cash Flow (FY2025)
$150.88M
Free Cash Flow Yield
10.78%

Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.